PKTX
ProtoKinetix, Inc.
Key Financials
Operating Income
$-24873956
↓ 12518.8%
Net Income
$-393650
↓ 8.1%
Revenue
$0
↓ 100.0%
Cash & Equivalents
$57568.00
↓ 70.2%
EPS (Diluted)
$0.00
NaN%
Total Liabilities
$44959.00
↑ 76.2%
Shareholders' Equity
$297940.00
↓ 12.9%
Total Assets
$483374.00
↑ 3.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 9/3/2026 | View on SEC |
| NT 10-Q | 8/14/2026 | View on SEC |
| 3 | 7/28/2026 | View on SEC |
| 3 | 7/7/2026 | View on SEC |
| 3 | 6/24/2026 | View on SEC |
| 8-K | 6/17/2026 | View on SEC |
| NT 10-Q | 5/15/2026 | View on SEC |
| NT 10-K | 3/31/2026 | View on SEC |
| D/A | 12/23/2025 | View on SEC |
| 8-K | 11/21/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PKTX |
| Company Name | ProtoKinetix, Inc. |
| CIK | 1128189 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 330-445-4971 |